<think>
Okay, let's tackle this problem step by step. The user wants me to parse a histopathology report for prostate cancer and extract three specific pieces of information into a structured JSON format. The three fields are Sampletype, Malignancy, and Gleason. 

First, I need to determine the sample type. The allowed values are "biopsy", "RP", "TURP", or "NA". Looking at the given report: "Näytteet kerätty vasemmasta ja oikeasta lohkosta eturauhasesta." The key term here is "kerätty" which translates to "collected". The report mentions taking samples from the left and right lobes of the prostate. The term "näytteet" (samples) doesn't specify the procedure type. Common sample types for prostate are biopsy, RP (radical prostatectomy), or TURP (transurethral resection). Since there's no mention of surgery like RP or TURP, and it's about collecting samples, it might be a biopsy. But the original Finnish text doesn't explicitly say "biopsia" (biopsy). However, in medical contexts, when samples are taken from the prostate lobes without specifying surgery, it's often a biopsy. But I need to be careful. Wait, the example given in the instructions had "Prostata biopsiasta" leading to "biopsy". Here, the term "kerätty" is more general. If the sample type isn't clearly stated, maybe it's safer to put "NA". But the user's example shows that even if the word "biopsiasta" is present, it's considered biopsy. Here, the absence of specific terms might lead to "NA". Hmm, but sometimes "näytteet kerätty" can imply biopsy. I'm a bit conflicted here. Let's check the original Finnish again. The sample is collected from the prostate lobes, which is typical for a biopsy. So maybe "biopsy" is correct here. But I need to confirm.

Next, the malignancy field. The report states: "Vaikea sanoa, onko näytteessä syöpään liittyviä muutoksia." Translating: "It's difficult to say if there are cancer-related changes in the sample." So the presence of malignancy is uncertain. The options are "kyllä" (yes), "ei" (no), or "NA". Since the report is uncertain, and there's no clear evidence of malignancy, but also no confirmation of absence, maybe "ei" (no) isn't right. But the user's instructions say that if there are no malignant findings, it's "ei". However, here the report says it's hard to tell. The example given in the problem had a clear malignancy, but in this case, the uncertainty might mean that malignancy isn't confirmed. The report mentions chronic inflammation and atrophy, but no definite signs of cancer. So perhaps malignancy is "ei" (no), but the pathologist is uncertain. Wait, the key is whether malignant findings are present. If the report says it's hard to say, but there's no mention of actual malignancy, then maybe the answer is "ei". Alternatively, if there's uncertainty, maybe "NA". But according to the problem's instructions, the second field is "Oliko näytteessä pahanlaatuisia löydöksiä" (Were there malignant findings in the sample). If the report says it's difficult to determine, but no malignancy is found, then the answer would be "ei". However, if the report is inconclusive, maybe "NA". The example given in the problem where the report was nonsensical resulted in all "NA". Here, the report is meaningful but inconclusive. The user's instructions say that only the worst lesion's results should be reported. Since there's no mention of malignancy, just uncertainty, perhaps the answer is "ei" (no) because no definite malignancy is found. But I need to be careful. The report says "onko näytteessä syöpään liittyviä muutoksia" (whether there are cancer-related changes in the sample). The answer is that it's hard to say. So the conclusion is that malignancy isn't confirmed. Therefore, the answer would be "ei" because there's no positive finding. Alternatively, if the report is uncertain, maybe "NA". But according to the problem's example, if the report is unclear, use "NA". However, in this case, the report is clear in stating that it's uncertain. The user's instructions for the second field: "ei" if no malignancy. So if the sample doesn't have malignant findings, it's "ei". Here, the pathologist can't confirm, but there's no positive finding. So the answer would be "ei".

Third, the Gleason score. The report doesn't mention any Gleason grades. The example shows that if there's no malignancy, Gleason is "NA". Since in this case, malignancy is "ei" (assuming), then Gleason would be "NA". 

Putting it all together:

Sampletype: The samples are collected from the prostate lobes. The procedure isn't explicitly stated. The term "kerätty" (collected) might refer to biopsy, but without explicit mention, maybe "NA". Wait, in the example, "Prostata biopsiasta" led to "biopsy". Here, the term "näytteet kerätty" (samples collected) from the prostate lobes. In medical context, this is likely a biopsy. So Sampletype would be "biopsy". But if the original text doesn't mention the procedure type, maybe "NA". However, in practice, when samples are taken from the prostate for analysis, it's typically a biopsy. So I think "biopsy" is correct here.

Malignancy: The report says it's hard to tell if there are cancer-related changes, but no malignancy is found. So "ei".

Gleason: Since malignancy is "ei", Gleason is "NA".

So the final JSON would be:

{
 "Sampletype": "biopsy",
 "Malignancy": "ei",
 "Gleason": "NA"
}

But wait, the user's example had a case where the report was nonsensical, leading to all "NA". Here, the report is meaningful but inconclusive on malignancy. The key is whether malignancy is present. The report doesn't state any malignancy, just uncertainty. So "Malignancy" should be "ei" because there's no positive finding. Therefore, the answer is as above.
</think>

```json
{
 "Sampletype": "biopsy",
 "Malignancy": "ei",
 "Gleason": "NA"
}
```